eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease

Hospital-Acquired Infections

Author: Quoc V Nguyen, MD, Assistant Professor, Department of Pediatrics, New York State Health Department
Contributor Information and Disclosures

Updated: Jan 14, 2009

Introduction

Background

Hospital-acquired infections (HAIs), also known as health-care–associated infections, encompass almost all clinically evident infections that do not originate from a patient's original admitting diagnosis. Within hours after admission, a patient's flora begins to acquire characteristics of the surrounding bacterial pool. Most infections that become clinically evident after 48 hours of hospitalization are considered hospital-acquired. Infections that occur after the patient's discharge from the hospital can be considered to have a nosocomial origin if the organisms were acquired during the hospital stay.

Pathophysiology

Within hours of admission, colonies of hospital strains of bacteria develop in the patient's skin, respiratory tract, and genitourinary tract. Risks factors for the invasion of colonizing pathogens can be categorized into 3 areas: iatrogenic, organizational, and patient-related.

  • Iatrogenic risk factors include pathogens on the hands of medical personnel, invasive procedures (eg, intubation and extended ventilation, indwelling vascular lines, urine catheterization), and antibiotic use and prophylaxis.
  • Organizational risk factors include contaminated air-conditioning systems, contaminated water systems, and staffing and physical layout of the facility (eg, nurse-to-patient ratio, open beds close together).
  • Patient risk factors include the severity of illness, underlying immunocompromised state, and length of stay.

Frequency

United States

The National Nosocomial Infections Surveillance (NNIS) System of the Centers for Disease Control and Prevention (CDC) performed a survey from October 1986 to April 1998.1 They ranked hospital wards according to their association with central-line bloodstream infections. The highest rates of infection occurred in the burn ICU, the neonatal ICU, and the pediatric ICU.

Nosocomial infections are estimated to occur in 5% of all acute-care hospitalizations; the incidence rate is 5 infections per 1,000 patient-days. Based on the 35 million patients admitted to 7,000 acute-care institutions in the United States, the incidence of HAIs is more than 2 million cases per year.2 HAIs result in an additional 26,250 deaths (range 17,500-70,000) and an added expenditure in excess of $4.5 billion.

International

The impact of HAIs on the health care systems of developed countries is significant and is proportionate to that of the United States.

Mortality/Morbidity

Nosocomial infections are estimated to more than double the mortality and morbidity risks of any admitted patient and probably result in as many as 70,000 deaths per year in the United States. This is the equivalent of 350,000 years of life lost in the United States.

Sex

HAIs do not have a discernible sex predilection. However, in the neonatal period, low birth weight and male sex (male-to-female ratio is 1.7:1) are associated with an increased risk of HAIs.

Age

Among bacterial HAIs, bacteremias and surgical site infections were more common in infants younger than 2 months than in older children. However, urinary tract infections (UTIs) were reported more frequently in children older than 5 years than in younger children.

Clinical

History

  • Nosocomial infections are caused by viral, bacterial, and fungal pathogens. These pathogens should be investigated in all febrile patients who are admitted for a nonfebrile illness.
  • During their hospital stay, many patients acquire viral respiratory infections (eg, influenza, parainfluenza, respiratory syncytial viruses) in the winter, rotaviral infections in winter, and enteroviral infections in the summer. Viruses are the leading etiologies of nosocomial infections in pediatric patients (responsible for ≤14% of hospital-acquired infections [HAIs] with identifiable pathogens).
  • Bacterial and fungal infections are less common. However, they are significantly associated with more morbidity and mortality. Most patients who are infected with nosocomial bacterial and fungal pathogens have a predisposition to infection caused by invasive supportive measures such as intubation and the placement of intravascular lines and urinary catheters. Fungal infections are more likely to arise from the patient's own flora; occasionally, they are caused by contaminated solutions (eg, those used in parenteral nutrition).

Physical

In addition to the presence of systemic signs and symptoms of infection (eg, fever, tachycardia, tachypnea, skin rash, general malaise), the source of HAIs may be suggested by the instrumentation used in various procedures. For example, an endotracheal tube may be associated with sinusitis, otitis, tracheitis and pneumonia; an intravascular catheter may be the source of phlebitis or line infection; and a Foley catheter may be associated with a candidal UTI.

Causes

  • Among 6,290 pediatric ICU patients surveyed between 1992 and 1997, the incidence of nosocomial invasive bacterial and fungal infections were as follows:3
    • Bloodstream infections - 28%
    • Ventilator-associated pneumonia - 21%
    • Urinary tract infection (UTI) - 15%
    • Lower respiratory infection - 12%
    • Gastrointestinal, skin, soft tissue, and cardiovascular infections - 10%
    • Surgical-site infections - 7%
    • Ear, nose, and throat infections - 7%
  • Nosocomial etiologies in bloodstream infections
    • Coagulase-negative staphylococci - 40%
    • Enterococci - 11.2%
    • Fungi - 9.65%
    • Staphylococcus aureus - 9.3%
    • Enterobacter species - 6.2%
    • Pseudomonads - 4.9%
    • Acinetobacter baumannii with substantial antimicrobial resistance - Reported with increasing frequency
  • Nosocomial etiologies in UTI
    • Gram-negative enterics - 50%
    • Fungi - 25%
    • Enterococci - 10%
  • Nosocomial etiologies in surgical-site infections
    • S aureus - 20%
    • Pseudomonads - 16%
    • Coagulase-negative staphylococci - 15%
    • Enterococci, fungi, Enterobacter species, and Escherichia coli - Less than 10% each
  • Nosocomial etiologies in fever
    • Viral infections are most common causes of nosocomial fevers.
    • Phlebitis is the second most common cause of nosocomial fevers in the hospitalized child.
    • Clostridium difficile colitis is also a cause of nonsocomial fevers.

More on Hospital-Acquired Infections

Overview: Hospital-Acquired Infections
Differential Diagnoses & Workup: Hospital-Acquired Infections
Treatment & Medication: Hospital-Acquired Infections
Follow-up: Hospital-Acquired Infections
References

References

  1. National Nosocomial Infections Surveillance (NNIS) System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control. Oct 1998;26(5):522-33. [Medline].

  2. Wenzel R, Edmond MD. The impact of Hospital Acquired Blood Stream Infections. Emerg Inf Dis. Mar-Apr 2001;7(174).

  3. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics. Apr 1999;103(4):e39. [Medline].

  4. Dancer SJ. Mopping up hospital infection. J Hosp Infect. Oct 1999;43(2):85-100. [Medline].

  5. Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2005.

  6. Deville JG, Adler S, Azimi PH, et al. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates. Pediatr Infect Dis J. Sep 2003;22(9 Suppl):S158-63. [Medline].

  7. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee [published erratum appears in Infect Control Hosp Epidemiol 1996 Apr;17(4):214]. Infect Control Hosp Epidemiol. Jan 1996;17(1):53-80. [Medline].

  8. McKibben L, Horan T, Tokars JI, et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control. May 2005;33(4):217-26. [Medline].

  9. Moellering RC Jr. Vancomycin-resistant enterococci. Clin Infect Dis. May 1998;26(5):1196-9. [Medline].

  10. Rice LB, Shlaes DM. Vancomycin resistance in the enterococcus. Relevance in pediatrics. Pediatr Clin North Am. Jun 1995;42(3):601-18. [Medline].

  11. Scott PT, Petersen K, Fishbain J. Acinetobacter baumannii Infections Among Patients at Military Medical Facilities Treating Injured US Service Members, 2002-2004. MMWR. 2004;53:1063-1066.

  12. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of Multidrug-Resistant Organisms in Health Care Settings, 2006. Atlanta, GA: Healthcare Infection Control Practices Advisory Committee; 2006. 1-74.

  13. Standfast SJ, Michelsen PB, Baltch AL. A prevalence survey of infections in a combined acute and long-term care hospital. Infect Control. Apr 1984;5(4):177-84. [Medline].

  14. Steed CJ. Common infections acquired in the hospital: the nurse's role in prevention. Nurs Clin North Am. Jun 1999;34(2):443-61. [Medline].

  15. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. MMWR Recommendations and Reports: Guidelines for Preventing Health Care-Associated Pneumonia. Atlanta, GA: CDC; March 26, 2004. 1-36.

  16. Weinstein JW, Mazon D, Pantelick E. A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity. Infect Control Hosp Epidemiol. Aug 1999;20(8):543-8. [Medline].

  17. Witte W, Braulke C, Cuny C, et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis. Jan 2005;24(1):1-5. [Medline].

Further Reading

Keywords

hospital-acquired infections, health care–acquired infections, nosocomial infection, vancomycin-resistant enterococcus, VRE, methicillin-resistant Staphylococcus aureus, MRSA, Pseudomonas, candidiasis, Legionella, respiratory syncytial virus, thrush, Clostridium difficile, viral respiratory infections, influenza, parainfluenza, sinusitis, otitis, tracheitis, phlebitis, line infection, bloodstream infection, ventilator-associated pneumonia, urinary tract infection, UTI, surgical-site infection, coagulase-negative staphylococci, enterococci, fungi, , pseudomonads,

Contributor Information and Disclosures

Author

Quoc V Nguyen, MD, Assistant Professor, Department of Pediatrics, New York State Health Department
Disclosure: Nothing to disclose.

Medical Editor

David Jaimovich, MD, Chief Medical Officer, Joint Commission International and Joint Commission Resources
David Jaimovich, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Joseph Domachowske, MD, Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York-Upstate Medical University
Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine
Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility
Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Consulting; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching; sanofi pasteur Grant/research funds Unrestricted research grant; sanofi pasteur  Consulting; sanofi pasteur Honoraria Speaking and teaching; Tap Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine
Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association
Disclosure: None None None

RELATED EMEDICINE ARTICLES
Patient Education
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.